Patient characteristics according to randomization arm
. | Arm A . | Arm B . | Arm C . | P . |
---|---|---|---|---|
No. patients | 197 | 198 | 197 | — |
Age | ||||
Median, y | 46.5 | 46 | 45 | .33 |
50 y or older, no. | 87 | 84 | 76 | .52 |
Male, no. | 119 | 105 | 101 | .15 |
De novo AML, no. | 177 | 185 | 180 | .44 |
Median WBC count, × 109/L | 11.5 | 11.2 | 7.2 | .88 |
Median platelet count, × 109/L | 59.5 | 55 | 59 | .86 |
Cytogenetics, no.* | ||||
Missing | 56 | 60 | 71 | ND |
Favorable | 19 | 19 | 18 | .57† |
Intermediate | 80 | 68 | 67 | — |
Unfavorable | 23 | 28 | 29 | — |
Unknown significance | 19 | 23 | 12 | — |
. | Arm A . | Arm B . | Arm C . | P . |
---|---|---|---|---|
No. patients | 197 | 198 | 197 | — |
Age | ||||
Median, y | 46.5 | 46 | 45 | .33 |
50 y or older, no. | 87 | 84 | 76 | .52 |
Male, no. | 119 | 105 | 101 | .15 |
De novo AML, no. | 177 | 185 | 180 | .44 |
Median WBC count, × 109/L | 11.5 | 11.2 | 7.2 | .88 |
Median platelet count, × 109/L | 59.5 | 55 | 59 | .86 |
Cytogenetics, no.* | ||||
Missing | 56 | 60 | 71 | ND |
Favorable | 19 | 19 | 18 | .57† |
Intermediate | 80 | 68 | 67 | — |
Unfavorable | 23 | 28 | 29 | — |
Unknown significance | 19 | 23 | 12 | — |